Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic CRC, gastric cancer (GC), SCCHN, or other tumors - Tabernero J, P.J., Hamid O et al (J Clin Oncol, 2013)